| P50 | author | Raymond J Steptoe | Q59556035 |
| | Andrew Wilkinson | Q63425858 |
| | Jeremy F Brooks | Q88154493 |
| | Geoffrey R Hill | Q38327210 |
| P2093 | author name string | Xiao Liu | |
| | Simon Phipps | |
| | Philip M Hansbro | |
| | Jay C Horvat | |
| | Janet M Davies | |
| | Rajeev Rudraraju | |
| | Malcolm R Starkey | |
| | Rhiannon B Werder | |
| | Soi-Cheng Law | |
| | Jane Al-Kouba | |
| P2860 | cites work | Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejection | Q39933853 |
| | Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. | Q40476204 |
| | Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. | Q40647086 |
| | Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens | Q41170875 |
| | Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. | Q41423746 |
| | Immunogenic, but not steady-state, antigen presentation permits regulatory T-cells to control CD8+ T-cell effector differentiation by IL-2 modulation. | Q41869061 |
| | Tolerance induction with gene-modified stem cells and immune-preserving conditioning in primed mice: restricting antigen to differentiated antigen-presenting cells permits efficacy | Q42282964 |
| | Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo | Q43687301 |
| | Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis | Q43959432 |
| | Targeting antigen to diverse APCs inactivates memory CD8+ T cells without eliciting tissue-destructive effector function | Q44234403 |
| | Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis | Q44800434 |
| | Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance. | Q44905201 |
| | Induction of B-cell tolerance by retroviral gene therapy | Q45259617 |
| | Gene therapy delivery of myelin oligodendrocyte glycoprotein (MOG) via hematopoietic stem cell transfer induces MOG-specific B cell deletion. | Q45862484 |
| | Conventional dendritic cells are the critical donor APC presenting alloantigen after experimental bone marrow transplantation | Q46140762 |
| | IL-4 receptor signaling in Clara cells is required for allergen-induced mucus production | Q47732346 |
| | T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma | Q48019510 |
| | Steady-state antigen-expressing dendritic cells terminate CD4+ memory T-cell responses. | Q51057483 |
| | Cognate CD4+ help elicited by resting dendritic cells does not impair the induction of peripheral tolerance in CD8+ T cells. | Q53573163 |
| | Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison. | Q55056712 |
| | Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements | Q57228054 |
| | Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses | Q57667259 |
| | Direct evidence that functionally impaired CD4+ T cells persist in vivo following induction of peripheral tolerance | Q58882235 |
| | Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy | Q60473182 |
| | Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma | Q62555671 |
| | Autoimmune diabetes is suppressed by transfer of proinsulin-encoding Gr-1+ myeloid progenitor cells that differentiate in vivo into resting dendritic cells | Q81333474 |
| | Steady-state dendritic cells continuously inactivate T cells that escape thymic negative selection | Q84185759 |
| | Helios defines T cells being driven to tolerance in the periphery and thymus | Q87697717 |
| | Molecular mechanisms for adaptive tolerance and other T cell anergy models | Q24671646 |
| | The cell biology of asthma | Q27009449 |
| | Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys | Q29615415 |
| | T cell exhaustion | Q29620463 |
| | Towards evidence-based medicine in specific grass pollen immunotherapy | Q33520325 |
| | Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. | Q33750748 |
| | Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study | Q34005065 |
| | Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells | Q34361879 |
| | Cytokine/anti-cytokine therapy - novel treatments for asthma? | Q34903133 |
| | Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes | Q34984972 |
| | Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy | Q35196374 |
| | High IFN-γ and low SLPI mark severe asthma in mice and humans | Q36040504 |
| | Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen | Q36340820 |
| | Persistent molecular microchimerism induces long-term tolerance towards a clinically relevant respiratory allergen | Q36651903 |
| | Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy | Q37008459 |
| | Understanding the mechanisms of viral induced asthma: new therapeutic directions | Q37072079 |
| | Harnessing regulatory T cells to suppress asthma: from potential to therapy | Q37680540 |
| | Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study | Q37689682 |
| | Allergy for a lifetime? | Q37698892 |
| | Potential therapeutic targets for steroid-resistant asthma | Q37735868 |
| | Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. | Q37802050 |
| | Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma | Q37841594 |
| | Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease | Q37847719 |
| | Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. | Q37859521 |
| | Emerging roles of pulmonary macrophages in driving the development of severe asthma | Q37980316 |
| | Virus infection and allergy in the development of asthma: what is the connection? | Q37987301 |
| | Induction of antigen-specific tolerance through hematopoietic stem cell-mediated gene therapy: the future for therapy of autoimmune disease? | Q38050613 |
| | Th2 cytokine antagonists: potential treatments for severe asthma | Q38057796 |
| | Novel immunotherapy vaccine development | Q38258988 |
| | Current developments for improving efficacy of allergy vaccines. | Q38503330 |
| | Molecular and transcriptional basis of CD4⁺ T cell dysfunction during chronic infection | Q38812394 |
| P433 | issue | 11 | |
| P577 | publication date | 2017-06-02 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation | |
| P478 | volume | 2 | |